Voximetry signs new collaboration with Gemelli University Hospital IRCCS

Voximetry is proud to announce a product evaluation and research collaboration agreement for Torch® voxel-based Dose Assessment with Fondazione Policlinico Universitario A. Gemelli IRCCS.  The collaboration intends to utilize Voximetry’s Torch® software* to research how a radiotherapeutic agent distributes in a specific patient and then report or predict the biologic effect on each tumor or […]

Voximetry Wins
“2022 Pressure Chamber”
Investor Pitch Competition

The Madison Wisconsin Chamber of Commerce “Pressure Chamber” event returned for its ninth year as emerging companies again competed for the coveted “golden suitcase,” as well as a reserved spot in the Chamber’s exclusive Greater Madison startup meetings with top Silicon Valley investment firms this fall. Over 300 companies competed to pitch in front of […]

Voximetry selected as finalist for the 2022 Wisconsin Innovation Awards

Voximetry is proud to announce we have been selected as a finalist from more than 300 businesses, products and services for the 2022 Wisconsin Innovation Awards. We are extremely grateful for the opportunity to share our exciting work on personalized RPT treatment planning making a difference for cancer patients everywhere. For more information, click here. […]

Voximetry will be at Theranostics World Congress, Wiesbaden Germany

Voximetry Inc., is pleased to support and participate in the 6th Theranostics World Congress in Wiesbaden Germany from June 24-26. We invite you to visit with us at the Voximetry booth SW02 and learn more about the latest news on advanced dosimetry guidance and how you can implement personalized RPT in your clinic.   *510(k) […]

Voximetry Awarded NIH SBIR Supplemental Grant

MADISON, Wis.–Voximetry Inc., a Healthtech software company with unique technology for personalized Radiopharmaceutical Therapy (RPT) has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to further advance development of its proprietary software for RPT dose assessment and treatment planning. According to Voximetry CEO, Dr. Sue Wallace, […]

Voximetry to Present at SNMMI Annual Meeting

Voximetry is looking forward to a busy week at the SNMMI in Vancouver! Dr. Chuck Stearns, Sr. Advanced Development Engineer will be presenting during the Saturday Categorical Seminar on “Key Factors in Quantitative PET Reconstruction“. Additionally, Voximetry is excited to highlight a poster “Impact of SPECT Reconstruction Methods on Voxel-Level Radiopharmaceutical Dosimetry”. Please visit us […]

FDA approves Pluvicto for Prostate Cancer

Novartis is a global medicine company using innovative science and digital technologies to create transformative treatments in areas of great medical need, including late-stage prostate cancer.  Today it was announced the Company had received FDA Approval for Pluvicto™, the first targeted radiopharmaceutical therapy (RPT) for treatment of progressive prostate cancer. Pluvicto (Lutetium-177 vipivotide tetraxetan, commonly […]

Strategic Investment in Medical Data Sharing & Standards

Clinical adoption of Personalized Treatment Planning for Radiopharmaceutical Therapy (RPT) depends upon seamless department workflows. Clinical images must be imported to the planning system, and the results of a plan assessment or an approved treatment plan must be exported to hospital data centers. This work is accomplished via complex data standards that continue to evolve. […]

Voximetry awarded second advance matching grant from WEDC

Voximetry, Inc. has been awarded a second SBIR Advance Matching grant sponsored by the Center for Technology Commercialization (CTC), part of the Wisconsin Economic Development Corporation (WEDC). This $100,000 award includes state match funding of Voximetry’s NIH SBIR Phase II grant, leadership training, and other resources to advance the commercialization of Small Business Innovation Research […]

Voximetry strengthens image processing capabilities

Voximetry announces another strategic product development investment with the hiring of Dr. Chuck Stearns. Dr. Stearns has over 30 years of experience in PET/CT scanner design, data processing and image reconstruction. “Chuck’s deep domain knowledge in nuclear medicine imaging technology will solidify Voximetry’s ability to focus on image data inputs to Torch™, our advanced dosimetry […]